| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |